DC Business DC
Novavax capitalizing on stock bump following coronavirus vaccine news
Novavax Inc. is already cashing in on its stock spike after announcing plans to develop a vaccine for the COVID-19 coronavirus. The Gaithersburg biotech has raked in $98.7 million…